Sunday , November 22 2026

Tag Archives: Lenacapavir

Uganda embarks on new HIV-PrEP study

Kampala, Uganda | THE INDEPENDENT | A new HIV Pre-exposure Prophylaxis (PrEP) study is underway to establish whether a six months-long injectable drug, Lenacapavir (LEN), and oral drug Descovy can protect HIV negative women and girls from acquiring the virus. The two-part study is being done by a team of researchers …

Read More »
Sahifa Theme License is not validated, Go to the theme options page to validate the license, You need a single license for each domain name.